CETA: A Very Reasonable Canadian-esque Compromise on Pharmaceutical Intellectual Property Law Changes

At long last, the Canadian Federal Government and the European Commission announced in October that a political agreement has been reached regarding the much anticipated Comprehensive Economic and Trade Agreement (CETA). Although the full-text of the agreement has yet to be revealed, Canadians have a pretty good idea of the way in which CETA will affect […]